A guide for the assessment and management of vitamin D status in people with intellectual disability (developed as an AADDM Working Party initiative)

Journal of Intellectual and Developmental Disability

Volumn 33, Issue 2, 2008, Pages 184-188

  Vanlint, Simon ^a   Nugent, Michael ^b   Durvasula, Seeta ^c   Downs, Jenny ^d   Leonard, Helen ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MODBURY HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Intellectual disability; Prevention; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

AUSTRALIA; BONE FRAGILITY; CLINICAL ASSESSMENT; DIET; FALL RISK; HEALTH CARE COST; HUMAN; HYPERCALCEMIA; INTELLECTUAL IMPAIRMENT; NEW ZEALAND; OSTEOPOROSIS; PATIENT MONITORING; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RISK ASSESSMENT; SCREENING; SHORT SURVEY; SUN EXPOSURE; SUNLIGHT; TREATMENT CONTRAINDICATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AUSTRALIA; HEALTH PROMOTION; HUMANS; MASS SCREENING; MENTAL RETARDATION; NEW ZEALAND; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; VITAMIN D DEFICIENCY; VULNERABLE POPULATIONS;

EID: 45849130931     PISSN: 13668250     EISSN: 14699532     Source Type: Journal    
DOI: 10.1080/13668250802015625     Document Type: Short Survey

References (34)

1. Autier, P., & Gandini, S. (2007). Vitamin D supplementation and total mortality. Archives of Internal Medicine, 167(16), 1730-1737.
2. Boland, R. (1986). Role of vitamin D in skeletal muscle function. Endocrine Reviews, 7, 434-438.
3. Brock, K., Wilkinson, M., Cook, R., Lee, S., & Bermingham, M. (2004). Associations with Vitamin D deficiency in "at risk" Australians. Journal of Steroid Biochemistry and Molecular Biology, 89-90, 581-588.
4. Calvo, M., Whiting, S., & Barton, C. (2005). Vitamin D intake: A global perspective of current status. Journal of Nutrition, 135, 310-316.
5. Center, J., Beange, H., & McElduff, A. (1998). People with mental retardation have an increased prevalence of osteoporosis: A population study. American Journal of Mental Retardation, 103(1), 19-28.
6. Chapuy, M., Arlot, M., Duboeuf, F., Brun, J., Crouzet, B., & Arnaud, S., et al. (1992). Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine, 327(23), 1637-1642.
7. Chaudhuri, A. (2004). Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Medical Hypotheses, 64, 608-618.
8. Diamond, T., Eisman, J. A., Mason, R. S., Nowson, C., Pasco, J. A., & Sambrook, P., et al. (2005). Vitamin D and adult bone health in Australia and New Zealand: A position statement. Medical Journal of Australia, 182(6), 281-285.
9. Diamond, T. H., Ho, K. W., Rohl, P. G., & Meerkin, M. (2005). Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: Efficacy & safety data. Medical Journal of Australia, 183(1), 10-12.
10. Dias, J., & Walker-Smith, J. (1990). Down's syndrome and coeliac disease. Journal of Pediatric Gastroenterology and Nutrition, 10(1), 41-43.
11. Ebeling, P., & Eisman, J. A. (2005). Recommendations from the Calcium and Vitamin D Forum. Medicine Today, 6(5), 43-50.
12. Foster, B., Walkley, J., & Temple, V. (2001). Bone mineral density status of women with intellectual disability. Adapted Physical Activity Quarterly, 18, 49-59.
13. Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., & Mohr, S. B., et al. (2006). The role of Vitamin D in cancer prevention. American Journal of Public Health, 96(2), 252-261.
14. Glick, N. R., Fischer, M. H., Heisey, D. M., Leverson, G. E., & Mann, D. C. (2005). Epidemiology of fractures in people with severe and profound developmental disabilities. Osteoporosis International, 16(4), 389-396.
15. Greenway, A., & Zacharin, M. (2003). Vitamin D status of chronically ill or disabled children in Victoria. Journal of Paediatric Child Health, 39(7), 543-547.
16. Grover, S. (2002). Menstrual and contraceptive management in women with an intellectual disability. Medical Journal of Australia, 176, 108-110.
17. Heaney, R. P. (2005). The Vitamin D requirement in health and disease. Journal of Steroid Biochemistry and Molecular Biology, 97(1-2), 13-19.
18. Holick, M., Matsuoka, L., & Wortsman, J. (1995). Regular use of sunscreen and vitamin D levels. Archives of Dermatology, 131(11), 1337-1339.
19. Kaunitz, A., Miller, P., Montgomery Rice, V., Ross, D., & McClung, M. (2006). Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: Recovery following discontinuation. Contraception, 74, 90-99.
20. Law, J., Durvasula, S., & McElduff, A. (2005). [Vitamin D status of people with developmental disability: A clinic based study.] Unpublished raw data.
21. Lips, P. (2004). Which circulating level of 25-hydroxyvitamin D is appropriate? Journal of Steroid Biochemistry and Molecular Biology, 89-90, 611-614.
22. Marks, R., Foley, P., Jolley, D., Knight, K., Harrison, J., & Thompson, S. (1995). The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Archives of Dermatology, 131(4), 415-421.
23. Mattson, R. H., & Gidal, B. E. (2004). Fractures, epilepsy, and antiepileptic drugs. Epilepsy and Behavior, 5(Suppl. 2), 36-40.
24. Morris, H., Morrison, G., Burr, M., Thomas, D., & Nordin, B. (1984). Vitamin D and femoral neck fractures in elderly South Australian women. Medical Journal of Australia, 140, 519-521.
25. Need, A., Morris, H., Horowitz, M., & Nordin, B. (1993). Effects of skin thickness, age, body fat and sunlight on serum 25-hydroxyvitamin D. American Journal of Clinical Nutrition, 58, 882-885.
26. Nordin, B. (2004). The role of vitamin D deficiency in hip fractures. Adelaide: The University of Adelaide, Institute of Medical & Veterinary Science.
27. O'Neill, S., MacLennan, A., Bass, S., Diamond, T., Ebeling, P., & Findlay, D., et al. (2004). Guidelines for the management of postmenopausal osteoporosis for GPs. Australian Family Physician, 33(11), 910-917.
28. Petty, S., Paton, L., O'Brien, T., Makovey, J., Erbas, B., & Sambrook, P., et al. (2005). Effect of antiepileptic medication on bone mineral measures. Neurology, 65, 1358-1363.
29. Reginster, J.-Y. (2005). The high prevalence of inadequate serum vitamin D levels and implications for bone health. Current Medical Research and Opinion, 21(4), 579-585.
30. Trivedi, D. P., Doll, R., & Khaw, K. T. (2003). Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. British Medical Journal, 326(7387), 469.
31. van der Mei, I., Ponsonby, A., Engelsen, O., Pasco, J., McGrath, J., & Eyles, D., et al. (2007). The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environmental Health Perspectives, 115(8), 1132-1139.
32. Vanlint, S., & Nugent, M. (2006). Vitamin D and fractures in people with intellectual disability. Journal of Intellectual Disability Research, 50, 761-767.
33. Vanlint, S., Nugent, M., Durvasula, S., Downs, J., & Leonard, H. (2008). Vitamin D and people with intellectual disability. Australian Family Physician, 37(5), 348-351.
34. Zittermann, A. (2003). Vitamin D in preventive medicine: Are we ignoring the evidence? British Journal of Nutrition, 89(5), 552-572.